Seres Therapeutics Stock Drops 7.39% to $2.09 – Market Cap $22.9M, 43.8% Monthly Decline
Seres Therapeutics stock dips 7.39% to $2.09, 43.8% month‑end drop; biotech firm targeting dysbiotic microbiomes and metabolic diseases.
- SERES THERAPEUTICS INC
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
One minute to read


